The Company announced the development of the first antiviral to combat BK virus, one of the most common viral infections in transplant patients CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics ...

Christopher Buck is fermenting a vaccine in his kitchen. You can too. Specifically, Buck brews and quaffs a hazy beer that ...

Orthogon’s small molecule therapeutics redefine treatment possibilities for BK virus infections. CANTON, Mass.–(BUSINESS WIRE)–December 10, 2024– Orthogon Therapeutics, a developer of novel antiviral ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. The BK virus, caught by most people in childhood, typically causes symptoms of the common cold.

Patients receiving a kidney transplant and who are positive for BK virus (BKV) are at risk of losing their transplant due to BKV reactivation. At this time, there are no antiviral options available ...

Single-cell analysis helps uncover how the BK virus replicates, opening the door to new drug targets. BK polyomavirus (BKPyV) is a major cause of kidney transplant failure. Without a complete ...

When Tim Tavender developed a common virus, he had no idea it was the start of what would later become a cancer diagnosis. The 51-year-old from Southampton became ill with BK virus, also known as ...

CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing round, exceeding its $5M target and bringing ...